Study of the Long Term Safety of Serlopitant for the Treatment of Pruritus (Itch)
Public ClinicalTrials.gov record NCT03540160. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
An Open-Label Long-Term Safety Study of Serlopitant for the Treatment of Pruritus
Study identification
- NCT ID
- NCT03540160
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Vyne Therapeutics Inc.
- Industry
- Enrollment
- 558 participants
Conditions and interventions
Conditions
Interventions
- 5 mg Serlopitant Tablets Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 14, 2018
- Primary completion
- Apr 7, 2020
- Completion
- Jun 16, 2020
- Last update posted
- May 19, 2021
2018 – 2020
United States locations
- U.S. sites
- 46
- U.S. states
- 25
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Study Site 504 | Birmingham | Alabama | 35233 | — |
| Study Site 204 | Fremont | California | 94538 | — |
| Study Site 383 | North Hollywood | California | 91606 | — |
| Study Site 356 | San Diego | California | 92108 | — |
| Study Site 514 | Santa Ana | California | 92701 | — |
| Study Site 501 | Aventura | Florida | 33180 | — |
| Study Site 210 | Coral Gables | Florida | 33134 | — |
| Study Site 534 | Fort Lauderdale | Florida | 33316 | — |
| Study Site 531 | Miami | Florida | 33155 | — |
| Study Site 222 | North Miami Beach | Florida | 33162 | — |
| Study Site 510 | Newnan | Georgia | 30263 | — |
| Study Site 388 | Skokie | Illinois | 60077 | — |
| Study Site 228 | Louisville | Kentucky | 40202 | — |
| Study Site 527 | New Orleans | Louisiana | 70115 | — |
| Study Site 525 | Glenn Dale | Maryland | 20769 | — |
| Study Site 506 | Ann Arbor | Michigan | 48103 | — |
| Study Site 515 | Detroit | Michigan | 48202 | — |
| Study Site 371 | Saint Joseph | Missouri | 64506 | — |
| Study Site 528 | St Louis | Missouri | 63110 | — |
| Study Site 227 | Omaha | Nebraska | 68144 | — |
| Study Site 526 | Henderson | Nevada | 89052 | — |
| Study Site 201 | East Windsor | New Jersey | 08520 | — |
| Study Site 529 | Verona | New Jersey | 07044-2946 | — |
| Study Site 507 | Brooklyn | New York | 11203 | — |
| Study Site 508 | Buffalo | New York | 14221 | — |
| Study Site 500 | New York | New York | 10025 | — |
| Study Site 517 | New York | New York | 10075 | — |
| Study Site 341 | High Point | North Carolina | 27262 | — |
| Study Site 516 | Bexley | Ohio | 43209 | — |
| Study Site 509 | Cleveland | Ohio | 44106 | — |
| Study Site 524 | Dublin | Ohio | 43016 | — |
| Study Site 112 | Tulsa | Oklahoma | 74136 | — |
| Study Site 523 | Philadelphia | Pennsylvania | 19104 | — |
| Study Site 522 | Pittsburgh | Pennsylvania | 15213 | — |
| Study Site 345 | Johnston | Rhode Island | 02919 | — |
| Study Site 343 | Spartanburg | South Carolina | 29303 | — |
| Study Site 511 | Knoxville | Tennessee | 37317 | — |
| Study Site 365 | Austin | Texas | 78745 | — |
| Study Site 520 | Bellaire | Texas | 77401 | — |
| Study Site 502 | Dallas | Texas | 75231 | — |
| Study Site 224 | Houston | Texas | 77004 | — |
| Study Site 359 | Pflugerville | Texas | 78660 | — |
| Study Site 226 | Webster | Texas | 77598 | — |
| Study Site 336 | Richmond | Virginia | 23220 | — |
| Study Site 806 | Spokane | Washington | 99202 | — |
| Study Site 532 | Morgantown | West Virginia | 26505 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 39 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03540160, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 19, 2021 · Synced Jul 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03540160 live on ClinicalTrials.gov.